Protein based COVID-19 vaccine

Description

In this Product Explainer, Infectious Disease Physician and Clinical Microbiologist A/Prof Paul Griffin explains the recombinant protein nanoparticle COVID-19 vaccine with a proprietary adjuvant, including the mechanism of action, efficacy, and tolerability; and provides an update on boosters, indications, and access
(8 mins).

Icon 2

NEXT LIVE Webcast

:
Days
:
Hours
:
Minutes
Seconds
Dr Richard Bradlow

Dr Richard Bradlow

Alcohol Addiction Assessment and Advice

Prof Rodney Baber AM

Prof Rodney Baber AM

Premature Ovarian Insufficiency – The New Guidelines

Dr Sam Mehr

Dr Sam Mehr

Paediatric Allergic Rhinitis & Immunotherapy

Dr Andrew Scroop

Dr Andrew Scroop

Inhaler Devices

Join us for the next free webcast for GPs and healthcare professionals

High quality lectures delivered by leading independent experts

Prof Paul Griffin

expert

Prof Paul Griffin

Infectious Diseases Physician and Clinical Microbiologist; Director of Infectious Diseases, Mater Hospital; Lecturer, University of Queensland

Date published: 12 July 2023